2025 · 1st Quarter (Jan 1 - Mar 31)

HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION

Filed by CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C..

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 16, 2025
Income: $10,000.00
Expenses: Not reported
Registrant: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Client: HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION
Filing UUID: 61a156c4-7a08-4812-933b-162526e7c18f
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

HR 1968, FY25 Full-Year Continuing Appropriations and Extensions Act; DoD research on vascular malformations

Literal federal measure citations: HR 1968

HCR · Health Issues

HR 8774/S 4921, FY25 Defense Appropriations Act and HR 1968, FY25 Full-Year Continuing Appropriations and Extensions Act; DoD research on vascular malformations; HR 9029/S 4942, FY 25 Labor-HHS Education Act, National HHT Center of Excellence Program

Literal federal measure citations: HR 8774, S 4921, HR 1968, HR 9029, S 4942

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.